🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Adaptive Trial Scheduling in Naming Treatment for Aphasia

RecruitingPhase 2Ages 18 Years - anyAllUniversity of Pittsburgh
NCT05653466 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Aphasia is a language disorder caused by stroke and other acquired brain injuries that affects over two million people in the United States and which interferes with life participation and quality of life. Anomia (i.e., word- finding difficulty) is a primary frustration for people with aphasia. Picture-based naming treatments for anomia are widely used in aphasia rehabilitation, but current treatment approaches do not address the long-term retention of naming abilities and do not focus on using these naming abilities in daily life. The current research aims to evaluate novel anomia treatment approaches to improve long-term retention and generalization to everyday life. This study is one of two that are part of a larger grant. This record is for sub-study 2, which will evaluate the benefits of adaptive trial spacing.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Existing diagnosis of chronic (\>6 months) aphasia subsequent to left hemisphere stroke. * Impaired performance on 2/8 sections of the Comprehensive Aphasia Test. * Must have access to a high-speed internet connection and be able to participate in telehealth. Exclusion Criteria: * History of other acquired or progressive neurological disease. * Significant language comprehension impairments * Unmanaged drug / alcohol dependence. * Severe diagnosed mood or behavioral disorders that require specialize mental health interventions.
💊

What it tests

  • Adaptive Spacing Condition
  • High-Item Non-Adaptive Spacing Condition
  • Low-Item Non-Adaptive Spacing Condition
📍

Where

1 site
Language Rehab and Cognition Lab, Department of Communication Sciences and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh
Pittsburgh, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy